Teva Pharmaceutical Industries Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TEVA | TAK | VTRS | UTHR | HLN | RDY | |
|---|---|---|---|---|---|---|
| Market cap | 48.02B | 59.67B | 20.15B | 23.59B | 41.78B | 10.68B |
| P/E (TTM) | 68.6 | — | — | 19.7 | 19.4 | 29.1 |
| Forward P/E | 13.4 | 35.2 | 6.6 | 16.3 | 15.4 | 20.0 |
| Price/book | 6.2 | 1.2 | 1.4 | 3.7 | 1.9 | 16.1 |
| Dividend yield | — | 3.29% | 2.72% | — | 2.12% | 0.67% |
| 1-year change | +104.72% | +36.52% | +78.90% | +24.79% | +2.64% | −13.09% |
| Today | +0.17% | −0.27% | −0.57% | +0.17% | +1.93% | +2.72% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All TEVA news ›Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives - Slideshow
(NYSE:TEVA) 2026-10-09 Seeking Alpha The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with this event.
Teva Pharmaceutical Industries Ltd (MEX:TEVA1N) Dividend
MEX:TEVA1N Dividend: Does Teva Pharmaceutical Industries Ltd Pay a Dividend? GuruFocus Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd (MEX:TEVA1N) Dividend Teva Pharmaceutical Industries Ltd (MEX:TEVA1N) does not…
Teva Pharmaceutical Industries gains FDA approval for monthly olanzapine
WELTRUZA is expected in three strengths in the coming weeks, with no post-injection observation required, Teva says. A once-monthly olanzapine injection gained U.S. approval Friday as Teva Pharmaceutical Industries Ltd. NYSETEVA prepared…
A Look at Teva Pharmaceutical Industries Ltd (TEVA) After 4.7% Gain -- GF Value $16.62 vs Price $41.10
On October 09, 2026, Teva Pharmaceutical Industries Ltd TEVA shares rose 4.7%, bringing the current price to $41.10. This price is situated within a 52-week range of $16.74 to $40.79, indicating significant volatility and an overall strong…
Israeli Pharma Giant Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza
Weltruza is Teva's second U.S.-approved product made in partnership with French biotech company Medincell. It uses long-acting injectable technology, designed to release medication over an extended period Teva said on Friday it had…
Teva: 'Hold' On FDA Approval Of Weltruza And Pivot To Growth Strategy
Teva stock is a "Hold" as its "Pivot to Growth" strategy shows early promise but requires further execution. Click for more on the TEVA stock. - I initiate Teva Pharmaceutical with a "Hold" rating, as its "Pivot to Growth" strategy shows…
Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot
NYSE-listed shares of Teva Pharmaceutical Industries (TEVA) rallied on Friday, touching fresh 52-week highs, after the company won U.S. FDA approval for a once-monthly schizophrenia injection, extending a strong year for the stock. TEVA…
FDA approves Teva’s once-monthly schizophrenia treatment
Israeli pharmaceutical giant Teva announced Friday that the US Food and Drug Administration (FDA) has approved WELTRUZA, a new once-monthly injectable treatment for adults with schizophrenia. The approval marks a significant milestone for…
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
The Manila Times UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC WARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. ("Tevogen” or the "Company”) (Nasdaq: TVGN), an integrated…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
gurufocus.com4
-
manilatimes.net3
-
quiverquant.com3
-
seekingalpha.com3
-
cnbc.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.